ZANOTTI, Laura
 Distribuzione geografica
Continente #
NA - Nord America 3.026
AS - Asia 1.280
EU - Europa 1.261
SA - Sud America 176
AF - Africa 31
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.780
Nazione #
US - Stati Uniti d'America 2.970
CN - Cina 436
SG - Singapore 403
PL - Polonia 367
UA - Ucraina 177
DE - Germania 175
HK - Hong Kong 155
BR - Brasile 151
IT - Italia 148
FI - Finlandia 101
VN - Vietnam 97
GB - Regno Unito 78
FR - Francia 61
TR - Turchia 42
IE - Irlanda 34
IN - India 34
RU - Federazione Russa 34
CA - Canada 33
BD - Bangladesh 21
SE - Svezia 17
ID - Indonesia 15
ES - Italia 14
IQ - Iraq 14
AR - Argentina 11
MX - Messico 11
NL - Olanda 11
ZA - Sudafrica 10
PK - Pakistan 9
CZ - Repubblica Ceca 7
KR - Corea 7
UZ - Uzbekistan 7
AT - Austria 6
BG - Bulgaria 6
JP - Giappone 6
TW - Taiwan 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
LT - Lituania 5
SA - Arabia Saudita 5
EC - Ecuador 4
KG - Kirghizistan 4
MA - Marocco 4
NG - Nigeria 4
NI - Nicaragua 4
CL - Cile 3
CR - Costa Rica 3
KE - Kenya 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
EG - Egitto 2
EU - Europa 2
JO - Giordania 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LV - Lettonia 2
MY - Malesia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GD - Grenada 1
IR - Iran 1
JM - Giamaica 1
LU - Lussemburgo 1
LY - Libia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TO - Tonga 1
TT - Trinidad e Tobago 1
Totale 5.780
Città #
Warsaw 367
Fairfield 332
Ashburn 298
Singapore 242
Woodbridge 234
Houston 175
Seattle 169
Chandler 141
Hong Kong 137
Jacksonville 133
San Jose 121
Cambridge 117
Wilmington 105
New York 103
Beijing 95
Ann Arbor 93
Dearborn 92
Helsinki 69
Los Angeles 69
The Dalles 66
Princeton 62
Nanjing 41
Brescia 40
Munich 36
Dublin 34
Istanbul 31
Shanghai 30
Lauterbourg 29
Des Moines 25
San Francisco 24
Council Bluffs 22
Dallas 22
Chicago 21
Dong Ket 20
Jinan 20
São Paulo 20
Buffalo 19
Ho Chi Minh City 19
London 19
Milan 17
Shenyang 16
Toronto 16
Hanoi 14
Orem 14
Turku 14
Central 13
Changsha 13
Santa Clara 13
Moscow 12
Nanchang 12
Hangzhou 11
Hebei 11
Kunming 10
Belo Horizonte 9
Chennai 9
Jiaxing 9
Redondo Beach 9
Rome 9
Stockholm 9
Tianjin 9
Denver 8
Jakarta 8
Paris 8
Poplar 8
San Diego 8
Ankara 7
Guangzhou 7
Boston 6
Brooklyn 6
Falkenstein 6
Lanzhou 6
Monmouth Junction 6
Phoenix 6
Tashkent 6
Zhengzhou 6
Brno 5
Brussels 5
Hefei 5
Johannesburg 5
Lahore 5
Manchester 5
Mexico City 5
Montreal 5
Mumbai 5
Norwalk 5
Sofia 5
Tokyo 5
Vienna 5
Abuja 4
Atlanta 4
Baghdad 4
Bishkek 4
Cape Town 4
Cazzago San Martino 4
Da Nang 4
Frankfurt am Main 4
Leawood 4
Managua 4
Miami 4
Milton Keynes 4
Totale 4.156
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 355
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 351
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 285
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 209
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 206
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 198
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 197
Altered immunolocalization of heat-shock proteins in human peri-implant gingiva 190
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 187
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 185
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 181
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 178
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 177
Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials 173
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 173
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination with Eribulin in Triple-Negative Breast Cancers 169
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 168
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 166
Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials 160
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 159
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 152
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 147
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 143
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 136
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 128
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 123
Room-temperature gas sensing based on visible photoluminescence properties of metal oxide nanobelts 118
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 115
Oxide nanobelts as conductometric gas sensors 111
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 111
Gas sensitive light emission properties of tin oxide nanobelts 107
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 102
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 96
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 91
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 66
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 45
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 11
Totale 5.869
Categoria #
all - tutte 24.449
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.449


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021225 0 0 0 0 0 0 0 0 0 121 64 40
2021/2022337 43 59 5 4 1 15 24 16 11 46 43 70
2022/2023361 57 24 19 25 28 67 3 37 63 4 16 18
2023/2024457 26 11 46 33 23 111 23 36 75 26 8 39
2024/2025705 6 15 7 103 45 85 54 35 72 42 150 91
2025/20261.572 165 166 110 231 209 138 269 61 104 119 0 0
Totale 5.869